NAMS
NewAmsterdam Pharma Company N.V.
23.20$
-4.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +111.2% | +15.4% | +26.7% | +47.4% | +82.1% | +2.0% | -13.5% | +42.2% | -7.8% | +5.1% | -4.8% | – | |
| – | +8.1% | +31.8% | +4.7% | -3.5% | +17.7% | +61.6% | -0.2% | -1.1% | -6.6% | +28.4% | +2.1% | – | |
| – | +256.1% | -208.5% | – | – | -28,600.0% | – | -330.3% | – | – | -10.3% | -64.8% | – | |
| – | -67.9% | +12,733.3% | -45.7% | -64.1% | -96.0% | +433.3% | +450.0% | -52.3% | +138.1% | -62.0% | +110.5% | – | |
| – | -99.9% | +12,733.3% | -45.7% | -64.1% | +82,805.3% | – | -5,673.9% | – | -943.6% | -45.6% | -58.6% | – | |
| – | -90.0% | +997,483.8% | -97.6% | -98.8% | +787,160.3% | -98.6% | -47.5% | +72.0% | +132.2% | -19.1% | -0.2% | – | |
| – | – | – | -135.8% | – | – | -106.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.